Costello J, Njue A, Lyall M, Heyes A, Mahler N, Philbin M, Nazareth T. Efficacy, safety, and quality-of-life of treatments for acute relapses of multiple sclerosis: results from a literature review of randomized controlled trials. Degener Neurol Neuromuscul Dis. 2019 Jul 1;9:55-78. doi: 10.2147/DNND.S208815
Graham J, Earnshaw S, Lim J, Luthra R, Borker R. Cost-effectiveness of afatinib versus erlotinib in the first-line treatment of patients with metastatic non-small cell lung cancer with EGFR Exon 19 deletion mutations. JCP. 2016 May;2(4):31-9.
Edwards T, Cadigan RJ, Evans JP, Henderson GE. Biobanks containing clinical specimens: defining characteristics, policies, and practices. Clin Biochem. 2014 Mar;47(4-5):245-51. doi: 10.1016/j.clinbiochem.2013.11.023
Dysktra LA, Granger AL. Interactions between the delta agonist SNC80, and the mu agonists, morphine, buprenorphine, and butorphanol in squirrel monkeys. Nida Res Monogr. 2000;180:65.
Gfroerer J, Lessler J, Parsley (Edwards) T. Studies of nonresponse and measurement error in the national household survey on drug abuse. Nida Res Monogr. 1997;167:273-95.